CD95, apoptosis pathways and cancer therapy

被引:0
作者
Debatin, KM [1 ]
机构
[1] Univ Ulm, Childrens Hosp, Ulm, Germany
关键词
D O I
10.1016/S0959-8049(99)81661-X
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1245
引用
收藏
页码:S307 / S308
页数:2
相关论文
共 50 条
  • [21] The role of CD95 and CD95 ligand in cancer (vol 22, pg 885, 2015)
    Peter, M. E.
    Hadji, A.
    Murmann, A. E.
    Brockway, S.
    Putzbach, W.
    Pattanayak, A.
    Ceppi, P.
    CELL DEATH AND DIFFERENTIATION, 2015, 22 (05) : 885 - 886
  • [22] Fas (CD95) mediated apoptosis in liver disease
    Schuchmann, M
    Strand, D
    Strand, S
    Galle, PR
    SHOCK, 2004, 21 : 83 - 83
  • [23] Fas (CD95)-mediated apoptosis in celiac disease
    Sträter, J
    Möller, P
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2001, 116 (04) : 616 - 617
  • [24] Fas/CD95 death receptor and lipid rafts: New targets for apoptosis-directed cancer therapy
    Mollinedo, Faustino
    Gajate, Consuelo
    DRUG RESISTANCE UPDATES, 2006, 9 (1-2) : 51 - 73
  • [25] Fas (CD95)-related apoptosis and rheumatoid arthritis
    Peng, SL
    RHEUMATOLOGY, 2006, 45 (01) : 26 - 30
  • [26] CD95 is unmutated in cultivated H-RS cells resistant to apoptosis via CD95/CD95L interaction.
    Re, D
    Hofmann, A
    Wolf, J
    Diehl, V
    Jox, A
    BLOOD, 1998, 92 (10) : 189B - 189B
  • [27] CD95 tyrosine phosphorylation is required for CD95 oligomerization
    Eberle, Andrea
    Reinehr, Roland
    Becker, Stephan
    Keitel, Verena
    Haeussinger, Dieter
    APOPTOSIS, 2007, 12 (04) : 719 - 729
  • [28] CD95 tyrosine phosphorylation is required for CD95 oligomerization
    Andrea Eberle
    Roland Reinehr
    Stephan Becker
    Verena Keitel
    Dieter Häussinger
    Apoptosis, 2007, 12 : 719 - 729
  • [29] Death Induced by CD95 or CD95 Ligand Elimination
    Hadji, Abbas
    Ceppi, Paolo
    Murmann, Andrea E.
    Brockway, Sonia
    Pattanayak, Abhinandan
    Bhinder, Bhavneet
    Hau, Annika
    De Chant, Shirley
    Parimi, Vamsi
    Kolesza, Piotre
    Richards, JoAnne
    Chandel, Navdeep
    Djaballah, Hakim
    Peter, Marcus E.
    CELL REPORTS, 2014, 7 (01): : 208 - 222
  • [30] CD95 (APO-1/FAS) AND THE CD95 LIGAND IN NORMAL AND MALIGNANT B-CELL APOPTOSIS
    DANIEL, PT
    MAPARA, MY
    BOMMERT, K
    BARGOU, RC
    KRAMMER, P
    DORKEN, B
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 831 - 831